Physician profile
Gavan Patrick Duffy
NPI 1265422182
$542,528.47
in general payments reported to CMS, 2019-2025
13 companies · $186K in 2025
The $186K reported for 2025 was more than what 95% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,586 · 2020: $26K · 2021: $64K · 2022: $71K · 2023: $99K · 2024: $92K · 2025: $186K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $363K · Consulting Fee: $12K · Travel and Lodging: $1,276 · Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $363,061.17 |
| Consulting Fee | $11,700.00 |
| Travel and Lodging | $1,276.19 |
| Food and Beverage | $740.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $523,057.48 | 2019-2025 | Attune |
| Medical Device Business Services, INC. | $18,495.75 | 2019-2025 | Attune |
| Depuy Synthes Sales INC. | $579.71 | 2020-2024 | Attune, Velys |
| Davol INC. | $156.09 | 2023 | |
| Horizon Therapeutics Plc | $64.39 | 2019-2020 | |
| Heron Therapeutics, INC. | $53.76 | 2021 | |
| Molnlycke Health Care US, LLC | $19.94 | 2024 | Mepilex Border Post-Op Ag |
| Dynasplint Systems INC. | $18.26 | 2025 | Dynasplint |
| Stryker Corporation | $18.13 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.10 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.76 | 2020 | |
| Kci USA, INC. | $15.69 | 2023 | 3m Soluprep |
| Convatec INC. | $15.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavan Duffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.